Endoscopic clipping prior to GVO vs. GVO in IGV1 bleeding: a multicenter retrospective clinical trial

Background and study aims Bleeding from isolated gastric varices type I (IGV1) is more dangerous and fatal than other types of esophageal variceal hemorrhages. However, optimum treatment for bleeding from IGV1 remains undefined. This retrospective study compared the efficacy of endoscopic clipping p...

Full description

Bibliographic Details
Main Authors: Huixian Li, Dong Ye, Ping Li, Derun Kong
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2019-10-01
Series:Endoscopy International Open
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/a-0902-4384
_version_ 1818148332399230976
author Huixian Li
Dong Ye
Ping Li
Derun Kong
author_facet Huixian Li
Dong Ye
Ping Li
Derun Kong
author_sort Huixian Li
collection DOAJ
description Background and study aims Bleeding from isolated gastric varices type I (IGV1) is more dangerous and fatal than other types of esophageal variceal hemorrhages. However, optimum treatment for bleeding from IGV1 remains undefined. This retrospective study compared the efficacy of endoscopic clipping prior to N-butyl-2-cyanoacrylate injection (GVO) and only GVO for treatment of IGV1. Patients and methods Data were collected retrospectively at three medical centers. Ninety-six patients were enrolled between March 2015 and April 2017 and divided into two groups: group I (patients with endoscopic clipping prior to GVO, n = 46) and group II (patients with only GVO, n = 50). Computed tomography angiography (CTA) was performed to evaluate the status of gastrorenal shunts (GRS). Results GRS was found in 59 of 66 patients (59/66). The groups did not differ in baseline characteristics. Initial hemostasis was successfully achieved in all patients. There was a significant difference in volume of N-butyl-2-cyanoacrylate administered (3.39 ± 1.20 mL in group I versus 2.53 ± 1.05 mL in group II (P = 0.03). Rebleeding occurred in 4.35% of patients in group I and 18.00 % in group II (P = 0.007). Variceal obliteration was achieved in all patients in group I and 72 % in group II (P < 0.001) with only one session. Rate of complications was similar in both the groups with the exception of one patient in group II who developed ectopic cerebral embolism. Conclusions Endoscopic clipping prior to GVO may be an appropriate alternative to GVO as a treatment modality for IGV1 bleeding.
first_indexed 2024-12-11T12:49:28Z
format Article
id doaj.art-9fbdd285fd9541d1ab88c08eac424c40
institution Directory Open Access Journal
issn 2364-3722
2196-9736
language English
last_indexed 2024-12-11T12:49:28Z
publishDate 2019-10-01
publisher Georg Thieme Verlag KG
record_format Article
series Endoscopy International Open
spelling doaj.art-9fbdd285fd9541d1ab88c08eac424c402022-12-22T01:06:45ZengGeorg Thieme Verlag KGEndoscopy International Open2364-37222196-97362019-10-010711E1365E137010.1055/a-0902-4384Endoscopic clipping prior to GVO vs. GVO in IGV1 bleeding: a multicenter retrospective clinical trialHuixian Li0Dong Ye1Ping Li2Derun Kong3Department of Gastroenterology, Anhui Geriatric Institute, The First Affiliated Hospital of Anhui Medical University, Anhui, ChinaDepartment of Infectious Diseases, Infectious Diseases Hospital of Handan City, Hebei, ChinaDepartment of Gastroenterology, Ditan Hospital affiliated of Capital Medical University, Beijing, ChinaDepartment of Gastroenterology, Anhui Geriatric Institute, The First Affiliated Hospital of Anhui Medical University, Anhui, ChinaBackground and study aims Bleeding from isolated gastric varices type I (IGV1) is more dangerous and fatal than other types of esophageal variceal hemorrhages. However, optimum treatment for bleeding from IGV1 remains undefined. This retrospective study compared the efficacy of endoscopic clipping prior to N-butyl-2-cyanoacrylate injection (GVO) and only GVO for treatment of IGV1. Patients and methods Data were collected retrospectively at three medical centers. Ninety-six patients were enrolled between March 2015 and April 2017 and divided into two groups: group I (patients with endoscopic clipping prior to GVO, n = 46) and group II (patients with only GVO, n = 50). Computed tomography angiography (CTA) was performed to evaluate the status of gastrorenal shunts (GRS). Results GRS was found in 59 of 66 patients (59/66). The groups did not differ in baseline characteristics. Initial hemostasis was successfully achieved in all patients. There was a significant difference in volume of N-butyl-2-cyanoacrylate administered (3.39 ± 1.20 mL in group I versus 2.53 ± 1.05 mL in group II (P = 0.03). Rebleeding occurred in 4.35% of patients in group I and 18.00 % in group II (P = 0.007). Variceal obliteration was achieved in all patients in group I and 72 % in group II (P < 0.001) with only one session. Rate of complications was similar in both the groups with the exception of one patient in group II who developed ectopic cerebral embolism. Conclusions Endoscopic clipping prior to GVO may be an appropriate alternative to GVO as a treatment modality for IGV1 bleeding.http://www.thieme-connect.de/DOI/DOI?10.1055/a-0902-4384
spellingShingle Huixian Li
Dong Ye
Ping Li
Derun Kong
Endoscopic clipping prior to GVO vs. GVO in IGV1 bleeding: a multicenter retrospective clinical trial
Endoscopy International Open
title Endoscopic clipping prior to GVO vs. GVO in IGV1 bleeding: a multicenter retrospective clinical trial
title_full Endoscopic clipping prior to GVO vs. GVO in IGV1 bleeding: a multicenter retrospective clinical trial
title_fullStr Endoscopic clipping prior to GVO vs. GVO in IGV1 bleeding: a multicenter retrospective clinical trial
title_full_unstemmed Endoscopic clipping prior to GVO vs. GVO in IGV1 bleeding: a multicenter retrospective clinical trial
title_short Endoscopic clipping prior to GVO vs. GVO in IGV1 bleeding: a multicenter retrospective clinical trial
title_sort endoscopic clipping prior to gvo vs gvo in igv1 bleeding a multicenter retrospective clinical trial
url http://www.thieme-connect.de/DOI/DOI?10.1055/a-0902-4384
work_keys_str_mv AT huixianli endoscopicclippingpriortogvovsgvoinigv1bleedingamulticenterretrospectiveclinicaltrial
AT dongye endoscopicclippingpriortogvovsgvoinigv1bleedingamulticenterretrospectiveclinicaltrial
AT pingli endoscopicclippingpriortogvovsgvoinigv1bleedingamulticenterretrospectiveclinicaltrial
AT derunkong endoscopicclippingpriortogvovsgvoinigv1bleedingamulticenterretrospectiveclinicaltrial